Drug recall D-0486-2026
Product
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Reason for recall
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Lots and codes
Lots# H03125, H03225, H03325, Exp Date: 2027/08
Recall details
- Recalling firm
- Leading Pharma, LLC, Fairfield, NJ
- Quantity
- 9384 bottles
- Distribution
- US Nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 20, 2026
Related products
- Furosemide – drug information
- NDC 69315-118 Furosemide · Furosemide 80 mg/1 · Leading Pharma, LLC
- NDC 69315-117 Furosemide · Furosemide 40 mg/1 · Leading Pharma, LLC
- NDC 69315-116 Furosemide · Furosemide 20 mg/1 · Leading Pharma, LLC